Cargando…

Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule

In a cross-sectional study, with the use of molecular methods, we aimed to gain insight into oropharyngeal pneumococcal colonization over time in 1212 Greek children recruited in general pediatric settings throughout the country; they were fully vaccinated with PCV13 (3 + 1 schedule). A single sampl...

Descripción completa

Detalles Bibliográficos
Autores principales: Syrogiannopoulos, George A., Grivea, Ioanna N., Moriondo, Maria, Nieddu, Francesco, Michoula, Aspasia N., Calabrese, Maria Rita, Anthracopoulos, Michael, Azzari, Chiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718523/
https://www.ncbi.nlm.nih.gov/pubmed/34969968
http://dx.doi.org/10.1038/s41598-021-03720-y
_version_ 1784624746654072832
author Syrogiannopoulos, George A.
Grivea, Ioanna N.
Moriondo, Maria
Nieddu, Francesco
Michoula, Aspasia N.
Calabrese, Maria Rita
Anthracopoulos, Michael
Azzari, Chiara
author_facet Syrogiannopoulos, George A.
Grivea, Ioanna N.
Moriondo, Maria
Nieddu, Francesco
Michoula, Aspasia N.
Calabrese, Maria Rita
Anthracopoulos, Michael
Azzari, Chiara
author_sort Syrogiannopoulos, George A.
collection PubMed
description In a cross-sectional study, with the use of molecular methods, we aimed to gain insight into oropharyngeal pneumococcal colonization over time in 1212 Greek children recruited in general pediatric settings throughout the country; they were fully vaccinated with PCV13 (3 + 1 schedule). A single sample was obtained from each child at a time interval of 26 days to 70 months after administration of the 4th (booster) PCV13 dose; sampling time was divided into six time intervals. Carriage of Streptococcus pneumoniae was detected by real-time PCR targeting the lytA gene and isolates were serotyped by singleplex real-time PCR assays. Multiple control procedures to avoid false-positive results were applied. We showed an overall S. pneumoniae carriage rate of 48.6%. Serotyping identified typeable isolates in 82% of the total lytA-positive samples. Non-PCV13 serotypes represented 83.8% of total isolates when excluding serogroups with mixed PCV13 and non-PCV13 serotypes. In multivariate analysis daycare/school attendance emerged as the main contributing factor. Notably, serotypes 19A and 3 were the only two PCV13 serotypes the colonization rate of which increased over time (χ(2) for trend P < 0.001 and P = 0.012, respectively). The application of the SP2020 gene on lytA-positive serotyped samples showed pneumococcal colonization in 97% of cases, and the overall colonization profile over time closely resembled that of the lytA gene. With the provisions of the methodological approach and age group of our study, the use of the oropharynx emerges as a reliable alternative to the nasopharynx in estimating pneumococcal carriage in epidemiological studies.
format Online
Article
Text
id pubmed-8718523
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-87185232022-01-05 Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule Syrogiannopoulos, George A. Grivea, Ioanna N. Moriondo, Maria Nieddu, Francesco Michoula, Aspasia N. Calabrese, Maria Rita Anthracopoulos, Michael Azzari, Chiara Sci Rep Article In a cross-sectional study, with the use of molecular methods, we aimed to gain insight into oropharyngeal pneumococcal colonization over time in 1212 Greek children recruited in general pediatric settings throughout the country; they were fully vaccinated with PCV13 (3 + 1 schedule). A single sample was obtained from each child at a time interval of 26 days to 70 months after administration of the 4th (booster) PCV13 dose; sampling time was divided into six time intervals. Carriage of Streptococcus pneumoniae was detected by real-time PCR targeting the lytA gene and isolates were serotyped by singleplex real-time PCR assays. Multiple control procedures to avoid false-positive results were applied. We showed an overall S. pneumoniae carriage rate of 48.6%. Serotyping identified typeable isolates in 82% of the total lytA-positive samples. Non-PCV13 serotypes represented 83.8% of total isolates when excluding serogroups with mixed PCV13 and non-PCV13 serotypes. In multivariate analysis daycare/school attendance emerged as the main contributing factor. Notably, serotypes 19A and 3 were the only two PCV13 serotypes the colonization rate of which increased over time (χ(2) for trend P < 0.001 and P = 0.012, respectively). The application of the SP2020 gene on lytA-positive serotyped samples showed pneumococcal colonization in 97% of cases, and the overall colonization profile over time closely resembled that of the lytA gene. With the provisions of the methodological approach and age group of our study, the use of the oropharynx emerges as a reliable alternative to the nasopharynx in estimating pneumococcal carriage in epidemiological studies. Nature Publishing Group UK 2021-12-30 /pmc/articles/PMC8718523/ /pubmed/34969968 http://dx.doi.org/10.1038/s41598-021-03720-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Syrogiannopoulos, George A.
Grivea, Ioanna N.
Moriondo, Maria
Nieddu, Francesco
Michoula, Aspasia N.
Calabrese, Maria Rita
Anthracopoulos, Michael
Azzari, Chiara
Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title_full Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title_fullStr Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title_full_unstemmed Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title_short Molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
title_sort molecular surveillance of pneumococcal carriage following completion of immunization with the 13-valent pneumococcal conjugate vaccine administered in a 3 + 1 schedule
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8718523/
https://www.ncbi.nlm.nih.gov/pubmed/34969968
http://dx.doi.org/10.1038/s41598-021-03720-y
work_keys_str_mv AT syrogiannopoulosgeorgea molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT griveaioannan molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT moriondomaria molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT nieddufrancesco molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT michoulaaspasian molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT calabresemariarita molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT anthracopoulosmichael molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule
AT azzarichiara molecularsurveillanceofpneumococcalcarriagefollowingcompletionofimmunizationwiththe13valentpneumococcalconjugatevaccineadministeredina31schedule